# US 2024/0180825 A1 · Polymer Liposome Hydrogel

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0180825 A1
- Document ID: US20240180825A1
- Status: Published application
- Kind: A1
- Application number: 18/285,315
- Filed: 2022-04-19
- Published: 2024-06-06
- Earliest claimed: 2021-04-20
- Assignees: The Board of Trustees of the Leland Stanford Junior University
- Applicants: The Board of Trustees of the Leland Stanford Junior University
- Inventors: Santiago Correa; John Klich; Eric Andrew Appel
- Web page: https://patentgrep.com/patent/US20240180825A1

## CPC

- A61K 9/06: Ointments; Bases therefor; {Other semi-solid forms, e.g. creams, sticks, gels (composition of ointments, creams or gels A61K47/00)}
- A61K 9/0019: {Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner (non-active ingredients are additionally classified in A61K47/00)}
- A61K 9/0024: {Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue (compositions for intravenous administration, normal injectable solutions or dispersions for, e.g. subcutaneous administration A61K9/0019; brain implants A61K9/0085; (coated) prostheses, catheters or stents A61L)}
- A61K 9/127: Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K 9/1271: Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers (liposomes as conjugates {A61K47/6911})
- A61K 47/38: Cellulose; Derivatives thereof
- C08J 3/075: Macromolecular gels
- C08J 2301/28: Alkyl ethers
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C08J: WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H (working, e.g. shaping, of plastics B29)

## Abstract

An injectable hydrogel network is provided distinguishing a non-covalently cross-linked hydrogel network with polymers functionalized with hydrophobic fatty pendant groups hydrophobically cross-linked with liposomal nanoparticles in which the liposomal nanoparticles are the cross-linkers. As the hydrogel is injectable, it is easily administered under the skin and does not require invasive surgical implantation. After injection the hydrogel rapidly self-heals to form a robust solid-like depot that can persist in the body over relevant timescales. The material does not cause a negative immune response like many other materials do. The hydrogel can gradually degrade over time in the body and therefore would not require surgical removal. Different embodiments modifying the surface chemistry of the liposomes give this hydrogel the ability to release therapeutic cargo, such as proteins, over controlled programmable timescales regardless of cargo size because the material can interact with the cargo through electrostatic or affinity interactions.

## Claims

### Claim 1

An injectable hydrogel network, comprising:
a non-covalently cross-linked hydrogel network with polymers functionalized with hydrophobic fatty pendant groups hydrophobically cross-linked with liposomal nanoparticles in which the liposomal nanoparticles are the cross-linkers.

### Claim 2 (depends on 1)

The injectable hydrogel network as set forth in claim 1, wherein the polymers functionalized with hydrophobic fatty pendant groups are dodecyl-modified hydroxypropyl methyl cellulose.

### Claim 3 (depends on 1)

The injectable hydrogel network as set forth in claim 1, wherein the liposomal nanoparticles further comprising affinity motifs capable of carrying and delivery of cargo.

### Claim 4 (depends on 1)

The injectable hydrogel network as set forth in claim 1, wherein the liposomal nanoparticles further comprising phospholipids capable of carrying and delivery of cargo.

### Claim 5 (depends on 1)

The injectable hydrogel network as set forth in claim 1, wherein the hydrophobic fatty pendant groups are defined as covalently attached functional groups bearing hydrophobic chemistries.

### Claim 6 (depends on 5)

The injectable hydrogel network as set forth in claim 5, wherein the attached functional groups are alkyl, alkenyl, alkynl, or aryl functional groups.
